Market Analysis dPCR and qPCR Market Explores New Growth 2019 | Page 2

Global DPCR and qPCR Market to 2025
www.theinsightpartners.com
The global dPCR and qPCR market is expected to reach US$ 6,371.6 Mn in 2025 from US$ 3,255.5 Mn in 2017. The
market is estimated to grow with a CAGR of 9.1% from 2018-2025.
dPCR and qPCR market is segmented by technology, product and application. Global dPCR and qPCR market, based on
technology was segmented into digital PCR (dPCR) and quantitative PCR (qPCR). Global dPCR and qPCR market, based
on the product was segmented into reagents & consumables, instruments, and software and services. The dPCR and
qPCR market, based on application was segmented into clinical applications, research applications, and forensic
applications.
Get Sample Report at https://www.theinsightpartners.com/sample/TIPHE100000817
dPCR and qPCR are PCR technologies which have evolved over the years from thermostable polymerases,
development of automated thermocyclers to latest digital PCR (d-PCR) methodologies. dPCR and qPCR have been
extensively used in molecular diagnostics and therefore have enabled detection of various diseases. The report would
be of an interest to various stakeholders operating in the dPCR and qPCR market. These stakeholders include
hospitals, research institutes, medical device suppliers, diagnostic centers, academic institutes, market research,
equipment manufacturers, and consulting firms.
The objective of the study is to describe, define, and forecast the dPCR and qPCR market by technology, product &
services, application, end user and region. The report also provide detailed information regarding the major factors
influencing growth of the market (drivers, restraints, opportunities, and trends). The report helps to analyze market with
respect to individual growth trends, prospects, and contributions to the overall market.
The report analyzes factors affecting dPCR and qPCR market from both demand and supply side and further evaluates
market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend.
The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and
South & Central America after evaluating political, economic, social and technological factors effecting the market in
these regions. The report also includes the profiles of key dPCR and qPCR manufacturing companies along with their
SWOT analysis and market strategies.
The prominent players operating in the market of dPCR and qPCR across the globe includes Abbott, F. Hoffmann-La
Roche Ltd., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., QIAGEN, TaKARA BIO, INC, Agilent Technologies,
Inc., bioMérieux SA, Danaher, and Fluidigm Corporation among others. For instance, in July 2017 Agilent Technologies
Inc. expanded its portfolio of instruments for molecular diagnostics with the introduction of the AriaDx Real-Time PCR
System. AriaDx is the only modular real-time PCR instrument on the market intended for in vitro diagnostic use. And the
launch expanded the business of the company in global dPCR and qPCR market.
Have Queries? Ask us at https://www.theinsightpartners.com/inquiry/TIPHE100000817
ABOUT US
2